A novel real-time genotyping assay for detection of the E6-350G HPV 16 variant

Journal of Virological Methods

Volumn 173, Issue 2, 2011, Pages 357-363

  Perez, S ^a   Cid, A ^b   Araujo, A ^a   Lamas, M J ^a   Saran, M T ^a   Alvarez, M J ^a   Lopez Miragaya, I ^a   Gonzalez, S ^a   Torres, J ^a   Melon, S ^c  

^a UNIVERSITY HOSPITAL COMPLEX OF VIGO   (Spain)

^b Complexo Hospitalario de Ourense ^*  (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Allelic discrimination; E6 350G variant; HPV 16; Real time PCR

Indexed keywords

ADULT; AGED; ALLELIC DISCRIMINATION REAL TIME POLYMERASE CHAIN REACTION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENETIC VARIABILITY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; NONHUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; UTERINE CERVIX CANCER; VIRUS DETECTION; VIRUS STRAIN;

ADOLESCENT; ADULT; AGED; ALLELES; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; MOLECULAR TYPING; MUTATION, MISSENSE; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; REPRESSOR PROTEINS; SENSITIVITY AND SPECIFICITY; SPAIN; YOUNG ADULT;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 79954617441     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.03.010     Document Type: Article

References (21)

1. Alemi M., Andersson S., Sällström J., Wilander E. Rapid test for identification of a human papillomavirus 16 E6 L83 V variant. Diagn. Mol. Pathol. 1999, 8:97-100.
2. Bernard H.U. The clinical importance of the nomenclature, evolution and taxonomy of human papillomaviruses. J. Clin. Virol. 2005, 32(Suppl. (1)):S1-6.
3. Bernard H.U., Calleja-Macias I.E., Dunn S.T. Genome variation of human papillomavirus types: phylogenetic and medical implications. Int. J. Cancer 2006, 118:1071-1076.
4. Berumen J., Ordoñez R.M., Lazcano E., Salmeron J., Galvan S.C., Estrada R.A., Yunes E., Garcia-Carranca A., Gonzalez-Lira G., Madrigal-de la Campa A. Asian-American variants of human papillomavirus 16 and risk for cervical cancer: a case-control study. J. Natl. Cancer Inst. 2001, 5(93):1325-1330.
5. Clifford G.M., Smith J.S., Plummer M., Muñoz N., Franceschi S. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br. J. Cancer 2003, 88:63-73.
6. de Villiers E.M., Fauquet C., Broker T.R., Bernard H.U., zur Hausen H. Classification of papillomaviruses. Virology 2004, 324:17-27.
7. Grodzki M., Besson G., Clavel C., Arslan A., Franceschi S., Birembaut P., Tommasino M., Zehbe I. Increased risk for cervical disease progression of French women infected with the human papillomavirus type 16 E6-350G variant. Cancer Epidemiol. Biomarkers Prev. 2006, 15:820-822.
8. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp. 1999, 41:95-98.
9. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans Human papillomaviruses. IARC Monogr. Eval. Carcinog. Risks Hum. 2007, 90:1-636.
10. Pande S., Jain N., Prusty B.K., Bhambhani S., Gupta S., Sharma R., Batra S., Das B.C. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India. J. Clin. Microbiol. 2008, 46:1060-1066.
11. Pista A., Oliveira A., Barateiro A., Costa H., Verdasca N., Paixão M.T. Molecular variants of human papillomavirus type 16 and 18 and risk for cervical neoplasia in Portugal. J. Med. Virol. 2007, 79:1889-1897.
12. Sabol I., Cretnik M., Hadzisejdić I., Si-Mohamed A., Matovina M., Grahovac B., Levanat S., Grce M. A new approach for the evaluation of the human papillomavirus type 16 variability with high resolution melting analysis. J. Virol. Methods 2009, 162:142-147.
13. Swan D.C., Limor J.R., Duncan K.L., Rajeevan M.S., Unger E.R. Human papillomavirus type 16 variant assignment by pyrosequencing. J. Virol. Methods 2006, 136:166-170.
14. Tamura K., Dudley J., Nei M., Kumar S. MEGA 4: molecular evolutionary genetics analysis (MEGA) software version 4.0. Mol. Biol. Evol. 2007, 24:1596-1599.
15. Thompson J.D., Higgins D.G., Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 1994, 22:4673-4680.
16. Wheeler C.M., Yamada T., Hildesheim A., Jenison S.A. Human papillomavirus type 16 sequence variants: identification by E6 and L1 lineage-specific hybridization. J. Clin. Microbiol. 1997, 35:11-19.
17. Wilkinson D.E., Baylis S.A., Padley D., Heath A.B., Ferguson M., Pagliusi S.R., Quint W.G., Wheeler C.M. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int. J. Cancer 2010, 126:2969-2983.
18. Xi L.F., Kiviat N.B., Hildesheim A., Galloway D.A., Wheeler C.M., Ho J., Koutsky L.A. Human papillomavirus type 16 and 18 variants: race-related distribution and persistence. J. Natl. Cancer Inst. 2006, 98:1045-1052.
19. Yamada T., Manos M.M., Peto J., Greer C.E., Munoz N., Bosch F.X., Wheeler C.M. Human papillomavirus type 16 sequence variation in cervical cancers: a worldwide perspective. J. Virol. 1997, 71:2463-2472.
20. Zehbe I., Wilander E., Delius H., Tommasino M. Human papillomavirus 16 E6 variants are more prevalent in invasive cervical carcinoma than the prototype. Cancer Res. 1998, 58:829-833.
21. Zuna R.E., Moore W.E., Shanesmith R.P., Dunn S.T., Wang S.S., Schiffman M., Blakey G.L., Teel T. Association of HPV 16 E6 variants with diagnostic severity in cervical cytology samples of 354 women in a US population. Int. J. Cancer 2009, 125:2609-2613.